Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Best Practices for Oncolytic Virus Design, Development, and Manufacturing | Contract Pharma

What are you searching for?

Sign in
White Papers / Tech Papers

Best Practices for Oncolytic Virus Design, Development, and Manufacturing

Best Practices For Oncolytic Virus Design, Development, and Manufacturing

Released By IDT Biologika

Oncolytic viruses, which exclusively target and break down cancer cells, have the potential to revolutionize standard cancer treatment. Though researchers are continuing to pursue the optimization of these viruses and their manufacture through a variety of viral engineering strategies, their continued progress hinges on meeting a number of goals linked to safety, efficacy, and commercial scale-up. These include high virus yields, highly reproducible key quality attributes, genetic stability, and formulation and product stability goals.

Download White Papers / Tech Papers Now

Download White Papers / Tech Papers Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters